PTGX
Protagonist Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website rotagonist-inc.com
- Employees(FY) 111
- ISIN US74366E1029
Performance
+8.74%
1W
+17.73%
1M
+9.59%
3M
+90.69%
6M
+34.06%
YTD
+16.75%
1Y
Profile
Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide-based drugs for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of erythrocytosis, iron overload, and other blood disorders; and JNJ-2113, an orally delivered investigational drug to block biological pathways that is in Phase II clinical trials for the treatment of moderate-to-severe plaque psoriasis; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist, which is in Phase II clinical trials for inflammatory bowel disease. The company has a license and collaboration agreement with Janssen Biotech, Inc. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
Investment Analysis Report: PTGX
Overview
PTGX is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $1.62 billion. In this report, we will conduct a comprehensive analysis of PTGX's financial statements over the past three years to evaluate its financial he...
Technical Analysis of PTGX 2024-05-10
Overview:
In analyzing the technical indicators for PTGX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-14 16:05
- 2024-05-14 04:05
- 2024-05-07 21:04
- 2024-05-07 16:23
Protagonist Therapeutics: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-07 16:10
- 2024-05-07 16:05
- 2024-05-07 11:53
- 2024-05-07 04:10
- 2024-05-07 04:05
- 2024-04-29 08:22
- 2024-04-16 09:00
- 2024-04-15 21:00
- 2024-04-05 12:00
- 2024-04-05 00:00
- 2024-04-03 01:52
Protagonist Therapeutics Inc CEO Sells 25,000 Shares(GuruFocus.com)
- 2024-04-01 12:19
- 2024-03-26 07:00
- 2024-03-25 19:00
- 2024-03-18 09:55
- 2024-03-18 07:00
- 2024-03-17 21:55
- 2024-03-17 19:00
- 2024-03-11 07:00
- 2024-03-10 19:00
- 2024-03-06 16:05
- 2024-03-06 03:05
- 2024-03-05 04:43
- 2024-03-03 07:46
- 2024-03-02 07:24
- 2024-03-01 12:20
Page 1 of 6
previousnext